From Targeting Somatic Mutations to Finding Inherited Cancer Predispositions: The Other Side of the Coin

The expanding use of tumor genome analysis by next generation sequencing to drive target therapies has led to increased germline findings in genes predisposing to hereditary cancer. These putative germline findings obtained from theranostic analyses, such as BRCA1/2 gene testing, large panels, whole...

Descripción completa

Detalles Bibliográficos
Autores principales: Pujol, Pascal, De La Motte Rouge, Thibault, Penault-Llorca, Frédérique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787697/
https://www.ncbi.nlm.nih.gov/pubmed/31357515
http://dx.doi.org/10.3390/diagnostics9030083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787697/
https://www.ncbi.nlm.nih.gov/pubmed/31357515
http://dx.doi.org/10.3390/diagnostics9030083

Ejemplares similares